BC

Birchview Capital Portfolio holdings

AUM $101M
This Quarter Return
+23.65%
1 Year Return
+34.62%
3 Year Return
+103.2%
5 Year Return
+107.72%
10 Year Return
+352.1%
AUM
$138M
AUM Growth
+$138M
Cap. Flow
-$18.7M
Cap. Flow %
-13.61%
Top 10 Hldgs %
79.11%
Holding
58
New
8
Increased
6
Reduced
5
Closed
6

Top Buys

1
BMY icon
Bristol-Myers Squibb
BMY
$47M
2
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$2.11M
3
CFRX
ContraFect Corporation
CFRX
$1.61M
4
CCXI
ChemoCentryx, Inc.
CCXI
$989K
5
SLNO icon
Soleno Therapeutics
SLNO
$794K

Top Sells

1
CELG
Celgene Corp
CELG
$69.5M
2
EQM
EQM Midstream Partners, LP
EQM
$1.5M
3
DOVA
Dova Pharmaceuticals, Inc. Common Stock
DOVA
$1.4M
4
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
$660K
5
DERM
Dermira, Inc.
DERM
$607K

Sector Composition

1 Healthcare 94.64%
2 Energy 1.7%
3 Consumer Staples 0.09%
4 Materials 0.06%
5 Consumer Discretionary 0.06%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BMY icon
1
Bristol-Myers Squibb
BMY
$96B
$50M 36.33% 778,585 +731,585 +1,557% +$47M
AXDX
2
DELISTED
Accelerate Diagnostics
AXDX
$36.9M 26.83% 2,183,795 – –
NBIX icon
3
Neurocrine Biosciences
NBIX
$13.8B
$5.91M 4.3% 55,000 – –
QDEL icon
4
QuidelOrtho
QDEL
$1.95B
$3.67M 2.66% 48,844 – –
OXFD
5
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$2.83M 2.05% 170,303 – –
VRML
6
DELISTED
Vermillion, Inc.
VRML
$2.61M 1.9% 3,221,933 – –
BMY.RT
7
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$2.11M 1.53% +699,648 New +$2.11M
CFRX
8
DELISTED
ContraFect Corporation
CFRX
$1.76M 1.28% 2,827,003 +2,600,000 +1,145% +$1.61M
EQM
9
DELISTED
EQM Midstream Partners, LP
EQM
$1.54M 1.12% 51,250 -50,000 -49% -$1.5M
KPTI icon
10
Karyopharm Therapeutics
KPTI
$61.7M
$1.53M 1.12% 80,000 +10,000 +14% +$192K
SLNO icon
11
Soleno Therapeutics
SLNO
$3.6B
$1.5M 1.09% 510,598 +270,000 +112% +$794K
BIIB icon
12
Biogen
BIIB
$19.4B
$1.48M 1.08% 5,000 – –
HROW icon
13
Harrow
HROW
$1.44B
$1.4M 1.02% 180,000 – –
VNDA icon
14
Vanda Pharmaceuticals
VNDA
$279M
$1.31M 0.95% 80,000 – –
AMRN
15
Amarin Corp
AMRN
$311M
$1.27M 0.92% 59,000 – –
MASI icon
16
Masimo
MASI
$7.59B
$1.26M 0.92% 8,000 – –
ARVN icon
17
Arvinas
ARVN
$568M
$1.23M 0.9% 30,000 – –
ALBO
18
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
$1.22M 0.89% 48,000 +10,000 +26% +$254K
DERM
19
DELISTED
Dermira, Inc.
DERM
$1.21M 0.88% 80,000 -40,000 -33% -$607K
GTHX
20
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$1.06M 0.77% 40,000 – –
ICPT
21
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$1.03M 0.75% 8,300 – –
ARNA
22
DELISTED
Arena Pharmaceuticals Inc
ARNA
$999K 0.73% 22,000 – –
XLRN
23
DELISTED
Acceleron Pharma Inc.
XLRN
$990K 0.72% 18,672 – –
CCXI
24
DELISTED
ChemoCentryx, Inc.
CCXI
$989K 0.72% +25,000 New +$989K
IMGN
25
DELISTED
Immunogen Inc
IMGN
$919K 0.67% 180,000 – –
1
2 3